Company: BLCO
Filing Date: 2025-07-30
Form Type: 10-Q
Source: 0001860742-25-000018
Chunk: 54

Company: Bausch & Lomb Corp
Filing Date: 2025-07-30
Form: 10-Q
Item: Item 8
Chunk 54
---
,278 $1,216 Six Months Ended June 30,20252024202520242025202420252024Pharmaceuticals$2 $2 $480 $452 $— $— $482 $454 Devices493 466 — — 427 403 920 869 OTC891 842 — — — — 891 842 Branded and Other Generics19 18 93 124 — — 112 142 Other revenues4 4 3 1 3 3 10 8 $1,409 $1,332 $576 $577 $430 $406 $2,415 $2,315 The top ten products/franchises represented 54% and 53% of total revenues for the six months ended June 30, 2025 and 2024, respectively.

30

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of OperationsINTRODUCTIONUnless the context otherwise indicates, as used in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” the terms “we,” “us,” “our,” “Bausch + Lomb,” the “Company,” and similar terms refer to Bausch + Lomb Corporation and its subsidiaries. This “Management’s Discussion and Analysis of Financial Condition and Results of Operations” has been updated through July 30, 2025 and should be read in conjunction with the unaudited interim Condensed Consolidated Financial Statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2025 (this “Form 10-Q”). The matters discussed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contain certain forward-looking statements within the meaning of Section 27A of The Securities Act of 1933, as amended (the “Act”), and Section 21E of The Securities Exchange Act of 1934, as amended, and that may be forward-looking information within the meaning defined under applicable Canadian securities laws (collectively, “Forward-Looking Statements”). See “Forward-Looking Statements” at the end of this discussion.Our accompanying unaudited interim Condensed Consolidated Financial Statements as of June 30, 2025 and for the three and six months ended June 30, 2025 and 2024 have been prepared in accordance